Home / Challenge areas / CanCOGeN / CanCOGeN timeline
CanCOGeN timeline
A pan-Canadian collaboration to fight COVID-19
Marking CanCOGeN's
first anniversary
Over the last year, genomics data has become one of the most powerful tools in Canada’s arsenal against COVID-19. As we mark the first anniversary of the Canadian COVID-19 Genomics Network (CanCOGeN), learn more about how this groundbreaking pan-Canadian initiative has met the pandemic challenge head on – from informing public health decision-making, to mobilizing a rapid response to new variants of concern, to improving Canada’s preparedness for future pandemics and public health challenges.
2020
January
First COVID-19 case in Canada
January
March
First SARS-CoV-2 genomes sequenced in Canada
- World Health Organization declares COVID-19 a global pandemic.
- Community transmission of SARS-CoV-2 confirmed in Canada.
- Genome Canada leads in proposing new national viral genomics network.
March
April
Canadian COVID-19 Genomics Network (CanCOGeN) launches with $40M federal investment
Canada passes 10k total COVID-19 cases.
April
May
CanCOGeN partners with COVID-19 Genomics UK Consortium
HostSeq and VirusSeq implementation Committees launch.
May
June
CanCOGeN-HostSeq Research Ethics Board approval enables patient recruitment to begin
- Canada passes 100K total COVID-19 cases.
- Dr. Catalina Lopez-Correa joins CanCOGeN as Executive Director.
June
July
First HostSeq study begins
July
August
VirusSeq members lead international team in publishing a SARS-CoV-2 data standard
- HostSeq Sequencing begins.
- VirusSeq establishes national quality. assurance/quality control criteria, now used in many countries.
- 10K viral sequences completed.
August
September
Variant of concern (B.1.1.7) emerges in the U.K.
September
October
Variant of concern (B.1.351) emerges in South Africa
October
December
Approval of first COVID-19 vaccine in Canada
- Variant of concern (B.1.1.248 (P.1)) emerges in Brazil.
- First COVID-19 vaccine administered in Canada.
- Canada passes 500K total COVID-19 cases.
- CanCOGeN mobilizes within hours of reports that a new SARS-CoV-2 variant is spreading in the U.K.
- First variant of concern case detected in Canada (B.1.1.7).
December
2021
February
CanCOGeN partners to support the Government of Canada Variants of Concern Strategy to track fast-spreading SARS-CoV-2 variants
- 50K viral sequences completed.
- 1K host sequences completed.
February
March
20K viral sequences shared on GISAID
March
April
Canada passes 1M total COVID-19 cases
- HostSeq has received 4K samples and sequenced 2K host genomes.
- Canadian VirusSeq Data Portal launched.
- 80K viral sequences completed.
April
2022
"Genome sequencing is a powerful tool in Canada's public health response to COVID-19, allowing decision-makers to respond rapidly to new outbreaks and variants of concern. The Government of Canada is proud to work hand-in-hand with Genome Canada and the CanCOGeN network and partners to ensure Canada's pandemic response is informed by real-time data and scientific evidence enabled by open data sharing and pan-Canadian collaboration. Since the launch of the Variants of Concern Strategy, CanCOGeN and its partners to ensure Canada's pandemic response is informed by real-time data and scientific evidence enabled by open data sharing and pan-Canadian collaboration. Since the launch of the Variants of Concern Strategy, CanCOGeN and its partners have been working to quickly scale up genomic sequencing and research efforts to detect new variants, increase real-time data sharing capacity, and inform appropriate public health responses."
Sr. Stephen Lucas,Deputy Minister of Health Canada (April 2021)
"As we mark one year of CanCOGeN, HostSeq has been established as a national project, enrolling multiple sites from coast to coast to coast, through a common project framework. HostSeq has completed whole genomic sequencing of over 2,000 Canadians affected by COVID-19. The genetic data, in combination with associated clinical data, will provide a deeper understanding of the association between the genetic variants in patient genomes and clinical outcomes, allowing for a better understanding of disease susceptibility, progression, response to treatments and vaccine efficacy. Sharing the data internationally will position Canada as a global partner in population genomic studies, laying new groundwork for our response to future national and global pandemics."
Dr. Naveed AzizChief Administrative & Chief Scientific Officer, CGEN (April 2021)
“A year ago, Genome Canada set out on a ground-breaking mission to tackle COVID-19 with the launch of CanCOGeN: a grassroots pan-Canadian effort driven by Genome Canada that brings together the regional Genome Centres, Canadian scientists, the National Microbiology Lab and provincial public health labs and partners. As we mark our first anniversary, the importance of national coordination and data sharing in Canada’s pandemic response cannot be overstated. CanCOGeN continues to advance genomic surveillance to inform critical public health decision-making and will ensure Canada has the national genomics data infrastructure and capacity to respond to future public health challenges.”
Dr. Catalina Lopez-CorreaExecutive Director, CanCOGeN (April 2021)
Previous
Next